Tajikistan
Diabetes country report 2011 — 2050
Number of adults (20–79 years) with diabetes in Tajikistan (TJ)
2011 | 155.5 thousand |
2024 | 383.5 thousand |
2050 | 670.4 thousand |
Tajikistan is one of the 60 countries and territories in the IDF Europe Region.
Data source(s) used for the diabetes estimates in adults:
- Estimates extrapolated from Turkmenistan and Uzbekistan.
Diabetes estimates (20-79 y) | ||||
---|---|---|---|---|
People with diabetes, in 1,000s | - | 155.5 | 383.5 | 670.4 |
Age-standardised prevalence of diabetes, % | - | 6.3 | 8.0 | 8.0 |
Proportion of people with undiagnosed diabetes, % | - | - | 56.7 | - |
People with undiagnosed diabetes, in 1,000s | - | - | 217.6 | - |
Impaired Fasting Glucose (IFG) | ||||
---|---|---|---|---|
People with IFG, in 1,000s | - | - | 236.9 | 373.3 |
Age-standardised prevalence of IFG, % | - | - | 4.7 | 4.4 |
Impaired Glucose Tolerance (IGT) | ||||
---|---|---|---|---|
People with IGT, in 1,000s | - | 152.4 | 146.7 | 315.3 |
Age-standardised prevalence of IGT, % | - | 6.0 | 3.5 | 4.1 |
Mortality attributable to diabetes (20-79 y) | ||||
---|---|---|---|---|
Deaths attributable to diabetes | - | 2,114.0 | 1,936.3 | - |
Proportion of diabetes-related deaths in people 20-79 y, % | - | - | 5.9 | - |
Hyperglycaemia in pregnancy (HIP) (20-49 y) | ||||
---|---|---|---|---|
Live births affected by HIP | - | - | - | - |
Prevalence of gestational diabetes mellitus (GDM), % | - | - | - | - |
Live births affected by other types of diabetes first detected in pregnancy | - | - | - | - |
Live births affected by other types of diabetes detected prior to pregnancy | - | - | - | - |
Diabetes-related health expenditure | ||||
---|---|---|---|---|
Total diabetes-related health expenditure, USD million | - | - | 61.4 | 97.4 |
Total diabetes-related health expenditure, ID million | - | - | 256.2 | 406.6 |
Diabetes-related health expenditure per person, USD | - | 61.0 | 160.1 | 145.3 |
Diabetes-related health expenditure per person, ID | - | - | 668.2 | 606.5 |
Type 1 diabetes estimates in children and adolescents | ||||
---|---|---|---|---|
People with type 1 diabetes (all age groups) | - | - | 4,465.0 | - |
People with type 1 diabetes (0-19 y) | - | - | 1,692.1 | - |
Demographics | ||||
---|---|---|---|---|
Total adult population (20-79 y), in 1,000s | - | 3,543.9 | 5,631.5 | 9,472.5 |
Population of children and adolescents (0-19 y) | - | - | 4,770,213.5 | - |
Diabetes estimates (20-79 y) | |
---|---|
People with diabetes, in 1,000s | - |
Age-standardised prevalence of diabetes, % | - |
Proportion of people with undiagnosed diabetes, % | - |
People with undiagnosed diabetes, in 1,000s | - |
Impaired Fasting Glucose (IFG) | |
---|---|
People with IFG, in 1,000s | - |
Age-standardised prevalence of IFG, % | - |
Impaired Glucose Tolerance (IGT) | |
---|---|
People with IGT, in 1,000s | - |
Age-standardised prevalence of IGT, % | - |
Mortality attributable to diabetes (20-79 y) | |
---|---|
Deaths attributable to diabetes | - |
Proportion of diabetes-related deaths in people 20-79 y, % | - |
Hyperglycaemia in pregnancy (HIP) (20-49 y) | |
---|---|
Live births affected by HIP | - |
Prevalence of gestational diabetes mellitus (GDM), % | - |
Live births affected by other types of diabetes first detected in pregnancy | - |
Live births affected by other types of diabetes detected prior to pregnancy | - |
Diabetes-related health expenditure | |
---|---|
Total diabetes-related health expenditure, USD million | - |
Total diabetes-related health expenditure, ID million | - |
Diabetes-related health expenditure per person, USD | - |
Diabetes-related health expenditure per person, ID | - |
Type 1 diabetes estimates in children and adolescents | |
---|---|
People with type 1 diabetes (all age groups) | - |
People with type 1 diabetes (0-19 y) | - |
Demographics | |
---|---|
Total adult population (20-79 y), in 1,000s | - |
Population of children and adolescents (0-19 y) | - |